Recent literature demonstrates that breast cancer is now among the top four most frequently diagnosed cancers in the Kingdom of Saudi Arabia (KSA). It is the most common cancer among women in KSA. For women undergoing treatment for breast cancer, pharmacists will play a pivotal role in their health care team.
The objective of this online program is to help educate and support pharmacists in the Kingdom of Saudi Arabia in understanding the current landscape of breast cancer- genetic mutations, risk factors, and selected newly approved therapies. There is also discussion about common adverse events associated with guideline-recommended treatment of breast cancer, and the role of pharmacists to help mitigate adverse events in their patients.
This program is supported by Novartis.